Alpha 1 Antitrypsin Deficiency (AATD) is a genetic disorder that predisposes individuals to lung and liver diseases. In the realm of pulmonary medicine, AATD stands as a significant challenge, particularly in its manifestation as Alpha 1 Lung Disease. As research advances and therapeutic options evolve, the landscape of the Alpha 1 Lung Disease market undergoes continuous transformation. In...